company

Q-APOTEKENE AS

1383 ASKER

Return on Equity
2,21 %
Current Ratio
0,82
Debt-to-Equity Ratio
1,47
Key figures (NOK)2022
Revenue304 000
Net Income124 000
Total Assets14 964 000
Total Equity5 610 000
Income (NOK)2022
Revenue304 000
Expenditure207 000
Operating Profit97 000
Financial Income357 000
Financial Costs330 000
Financial Balance27 000
Earnings Before Tax124 000
Tax0
Net Income124 000
Balance (NOK)2022
Total Fixed Assets14 064 000
Total Current Assets900 000
Total Assets14 964 000
Total Retained Equity5 491 000
Total Equity5 610 000
Total Long-Term Debt8 264 000
Total Current Debt1 091 000
Total Equity and Debt14 964 000
Cash flow (NOK)2022
Sales Income0
Other Income304 000
Revenue304 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure207 000
Operating Profit97 000
Financial Income357 000
Financial Costs330 000
Financial Balance27 000
Dividends0
Net Income124 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate14 022 000
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets14 022 000
Total Fiancial Fixed Assets42 000
Total Fixed Assets14 064 000
Stock0
Total Investments831 000
Cash, Bank63 000
Total Current Assets900 000
Total Assets14 964 000
Total Equity5 610 000
Short-Term Group Debt0
Total Long-Term Debt8 264 000
Creditors3 000
Unpaid Taxes0
Dividends0
Other Current Debt1 088 000
Total Current Debt1 091 000
Total Equity and Debt14 964 000
Financial indicators2022
Return on Equity2,21 %
Debt-to-Equity Ratio1,47
Operating Profit Margin31,91 %
Current Ratio0,82
Quick Ratio0,82
Equity Ratio0,37
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English